modelNalmefene_Kyhl2016_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.

Information

name:nalmefene
ATC code:N07BB05
model:one compartment, IV dosing (PK_1C)
source:Kyhl LE et al. 2016
population:healthy subjects
measured compound:nalmefene
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
systemic clearance60.4l h(-1)CL
central volume of distribution266lV
Absolute oral bioavailability without food intake41%Fab

About nalmefene

Nalmefene is an opioid antagonist used to treat alcohol dependence and has been studied for opiate dependence. It is authorised in the European Union as a medicine for alcohol-related disorders.

Summary written by glm-5.3-flash from Wikidata Q4353252 and the WHO ATC classification and the EMA medicines list; not checked by a person.

Identity, molar mass and metabolites: Nalmefene.

References

  1. Kyhl LE et al. (2016). Population pharmacokinetics of nalmefene in healthy subjects and its relation to μ-opioid receptor occupancy. British journal of clinical pharmacology 81(2):290–300. DOI:10.1111/bcp.12805 PUBMED:26483076

Parameters

TypeNameDefaultDescription
RealCl_ref1.677777777777778e-05Cl [m3/s]
RealVd_ref0.266Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Kyhl_2016: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate